Value of Montelukast as a potential treatment of Post COVID-19 Persistent cough: A randomized controlled pilot study
A. Mohamed-Hussein (Assiut, Egypt), I. Galal (Aswant, Egypt), M. Ibrahim (Assiut, Egypt), H. Makhlouf (Assiut, Egypt), N. Makhlouf (Assiut, Egypt), H. Abdel Aal (Assiut, Egypt), K. Kholief (Assiut, Egypt)
Source: International Congress 2022 – COVID treatments
Session: COVID treatments
Session type: Thematic Poster
Number: 2601
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Mohamed-Hussein (Assiut, Egypt), I. Galal (Aswant, Egypt), M. Ibrahim (Assiut, Egypt), H. Makhlouf (Assiut, Egypt), N. Makhlouf (Assiut, Egypt), H. Abdel Aal (Assiut, Egypt), K. Kholief (Assiut, Egypt). Value of Montelukast as a potential treatment of Post COVID-19 Persistent cough: A randomized controlled pilot study. 2601
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|